VAN BUREN TOWNSHIP, Mich. – On Dec. 11, Visteon Corp. received notification from the New York Stock Exchange (NYSE) that the company had fallen below a continued listing standard that requires the company’s average total market capitalization over a consecutive 30 trading-day period to equal or exceed $75 million and, at the same time, total reported stockholders’ equity to equal or exceed $75 million.

Under NYSE rules, Visteon has 45 days from receipt of this notice to submit a plan to the NYSE to demonstrate its ability to achieve compliance with the continued listing requirements within 18 months. Visteon said it intends to submit such a plan. If the NYSE accepts Visteon’s plan, Visteon’s common stock will continue to be listed on the NYSE during the cure period, subject to ongoing monitoring and the company’s compliance with other NYSE continued listing requirements.